About

Our mission is to improve patients’ lives by providing every orthopaedic surgeon and their care team access to effective, easy-to-use technologies.

Fundamentally, we’re problem solvers. Intellijoint Surgical® offers solutions to orthopaedic surgeons using technology that’s free of needless complexities. We build with surgeons, for surgeons, to create versatile devices that provide important information in a variety of use-cases. We aren’t prescriptive when it comes to workflow, approach or implant. Our solutions are fast and straightforward—exactly what surgeons need and no more. We partner with clinicians and surgical staff to improve patients’ lives using efficient and cost-effective technological solutions. Valuable information and guidance to eliminate guesswork—that’s the Intellijoint guarantee.

Since commercializing in 2016, Intellijoint has supported over 75,000 total joint replacements in Canada, the United States, Australia, New Zealand and Japan. We’ve expanded our product suite having developed a surgical planning & navigation solution for total hip and knee joint replacements. We are proudly Canadian and remain focused on being a global leader in medical technology. Our expansion is fuelled by our desire to provide homegrown innovation. In keeping with our values, Intellijoint founded the Medical Innovation Xchange to make it easier for younger companies in our industry to stay Canadian.

Leadership Team

A team dedicated to creating an open, transparent, collaborative culture that keeps its promises to our customers, people and partners, as well as the communities we work in.

Learn more

Join the Team

As IJS continues to grow in both Canada and the U.S., we are looking for the best talent to join our team of strong and passionate people. Check out our current job openings, there might be something for you!

View career opportunities

2010

Intellijoint Surgical (formerly called Avenir Medical) founded.

2013

Intellijoint HIP™ received its Health Canada Device Medical Licence.
First clinical use of Intellijoint HIP at Mount Sinai Hospital in Toronto, Canada.
Intellijoint receives ISO 13485 certification.
Intellijoint granted its first key method and system patent by US Patent Office for “Aligning a prosthesis during surgery using active sensors”.

2014

Intellijoint HIP receives FDA clearance.
Limited launch of Intellijoint HIP.
First surgery performed using Intellijoint HIP in the United States.

2015

The next generation of Intellijoint HIP receives its Health Canada Medical Device Licence.
First clinical use & launch of the next generation of Intellijoint HIP in Canada.
Intellijoint granted key patent by US Patent Office related to its core technology for “Method and system for aligning a prosthesis during surgery”.
Next Generation of Intellijoint HIP receives FDA clearance.

2016

Intellijoint awarded North American Frost & Sullivan Enabling Technology Leadership Award.
First surgery performed using the next generation of Intellijoint HIP in the US.
Launched the next generation of Intellijoint HIP in select US cities.
400th surgery performed using Intellijoint HIP.
Intellijoint Surgical wins Futurpreneur Shopify True Grit Award 2016.
First successful clinical use of Intellijoint HIP’s Direct Anterior Approach Application.

2017

Intellijoint HIP Anterior receives FDA clearance.
Intellijoint celebrates 1,000 procedures completed with Intellijoint HIP by launching 1,000 Thanks campaign.
Intellijoint receives CE Mark Approval flagship product Intellijoint HIP.

2018

Intellijoint HIP available in Australia and New Zealand.

2019

Intellijoint ranks 2nd on Deloitte’s Technology Fast 50™ companies.
Intellijoint ranks 13th on the Startup 50 List of Canada’s Top New Growth Companies by Canadian Business and Maclean’s.
Intellijoint HIP passes the 10,000 case milestone.

2020

Intellijoint ranks first on Deloitte’s Technology Fast 50™ companies.
Intellijoint ranks No. 37 on The Globe and Mail’s second-annual ranking of Canada’s Top Growing Companies.
Intellijoint KNEE™ launches in North America.